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As an agent potentially capable of inducing ischemia in 
patients with coronary artery disease, dopamine admin-
istered intravenously was evaluated as a pharmacologic 
stress agent by supine radionuclide angiography, and 
the results were compared with ergometer exercise. In 
a preliminary group of 11 subjects (4 normal subjects 
and 7 patients with coronary disease), dopamine alone 
was administered in increments of 2.5 JLg/kg per min to 
a maximum of 15 JLg/kg per min. There were significant 
differences between exercise and dopamine in maximal 
stress heart rates, 129.3 ± 30.0 versus 88.0 ± 35.8 
beats/min (p < 0.05) in normal subjects and 118.9 ± 
21.1 versus 87.6 ± 22.6 beats/min (p < 0.05) in patients 
with coronary disease, as well as in maximal stress rate-
pressure products, 213.3 ± 51.4 versus 155.0 ± 52.5 
mm Hg/min x 102 (p < 0.02) in normal subjects and 
216.0 ± 45.6 versus 161.0 ± 48.6 mm Hg/min x 102 
(p < 0.0(3) in patients with coronary disease. As a result, 
in these patients the ejection fraction response was sig-
nificantly different: - 3.3 ± 4.5 % with exercise versus 
+ 6.3 ± 4.6% with dopamine (p < 0.05). 
In a second group of 41 subjects (9 normal subjects 
and 32 patients with coronary disease), atropine (0.6 mg) 
was administered intravenously before and after every 
second dopamine dose increment. This produced statis-
With the development of radionuclide angiography, studies 
performed at rest and during exercise have been used ex-
tensively in the noninvasive assessment of patients with 
suspected coronary artery disease. It has been postulated 
that the development of ischemia during exercise leads to 
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tically similar maximal stress heart rates as compared 
with exercise in all subjects, rate-pressure products in 
normal subjects and slightly higher values with dopa-
mine in patients with coronary disease: 200.3 ± 47.2 
versus 183.1 ± 43.0 (p < 0.05). 
The ejection fraction response was similar in normal 
subjects, + 1.8 ± 6.6% with exercise versus + 4.3 ± 
4.5% with dopamine, but dissimilar in patients with 
coronary artery disease, - 3.2 ± 7.0 versus + 2.5 ± 
8.2% (p < 0.005). The sensitivity for patients with coro-
nary disease was 91 and 56% for exercise and dopamine, 
respectively, if a criterion of an increase of less than 5 % 
in ejection fraction was used; respective sensitivity was 
94 and 66% for an increase of less than 7% and 97 and 
78% for an increase of less than 10%. The lack of cor-
relation in ejection fraction response may have been due 
to slight differences in baseline hemodynamic values and 
in inotropic or metabolic effects, or both, of dopamine 
in comparison with exercise. 
Dopamine, by failing to produce ischemia of the same 
degree or frequency as that produced by exercise, would 
not appear suitable as a pharmacologic alternative to 
exercise stress. 
(J Am Coli CardioI1985;6:84-92) 
stress-related left ventricular dysfunction manifested by the 
development of abnormalities in global and regional ejection 
fraction response. In a significant percent of patients sub-
jected to exercise radionuclide angiography, even in the 
presence of significant coronary disease, the test proves to 
be inconclusive. The inability to provoke ischemia is often 
due to failure to achieve a satisfactory heart rate response. 
This may occur because of peripheral vascular disease af-
fecting the lower limbs, musculoskeletal disorders, central 
nervous system disease, lack of physical fitness or unwill-
ingness of the patient to perform adequately. 
Recently, alternative forms of stress have been proposed. 
Both the cold pressor test (1-3) and isometric hand grip (4) 
0735-1097/85/$3.30 
JACC Vol. 6, No. I 
July 1985:84--92 
have been used in conjunction with radionuclide angiog-
raphy. However, neither of these two methods produces the 
complete constellation of changes seen during exercise, 
namely, marked increases in heart rate and blood pressure 
and catecholamine-mediated stimulation of myocardial con-
tractility. Before the advent of radionuclide angiography, 
catechoiamine infusions had been demonstrated to produce 
evidence of myocardial ischemia in patients with coronary 
disease (5-8). Our investigation was undertaken, therefore, 
to assess the effect of intravenous dopamine in patients 
admitted for diagnostic coronary angiography. 
Methods 
Study patients. Fifty-two patients with suspected coro-
nary artery disease admitted electively for cardiac catheter-
ization were studied. No patient had either historical or 
electrocardiographic evidence of prior myocardial infarc-
tion. There were 41 men and 11 women aged 37 to 69 years 
(mean 54.2 ± 8.0). Twenty-four patients had New York 
Heart Association class I or II symptoms, while 28 had class 
III or IV symptoms. Those patients in class I or II had beta-
adrenergic blocking agents discontinued 48 hours before the 
study and nitrate or calcium antagonists, or both, discon-
tinued the morning of the procedure, at least 6 hours before 
the study. Those patients in class III or IV had beta-adren-
ergic blocking agents continued in the clinically prescribed 
doses throughout the period of study, while nitrates and 
calcium antagonists were discontinued the morning of the 
procedure. Patients with uncontrolled hypertension or evi-
dence of valvular heart disease were excluded. 
Cardiac catheterization. Cardiac catheterization was 
performed within 24 hours of radionuclide angiography, 
with no clinical changes in status between studies. All stud-
ies were performed by the Judkins technique with simul-
taneous biplane views for all coronary arteriograms. Arte-
riograms were analyzed by two experienced observers unaware 
of the results of radionuclide angiography. Significant coro-
nary artery disease was defined as the presence of at least 
70% luminal diameter narrowing of one or more major 
coronary vessels. No subject defined as normal had a ste-
nosis greater than 50%, and all normal subjects, in addition, 
had normal left ventricular function at rest. 
Radionuclide angiography. Equilibrium-gated blood 
pool angiography was performed in all patients using au-
tologous blood cells labeled by the in vitro technique (9). 
All images were acquired in the supine position, with the 
patient's legs elevated before and during the exercise portion 
of the study and with the legs down, in the same plane as 
the torso, before and during dopamine infusion. 
Images were obtained by a Picker 4/15 large field of view 
camera, equipped with a high sensitivity, parallel-hole col-
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limator interfaced to a Digital Equipment Corporation PDP 
11/34 computer. Images were acquired by dividing the car-
diac cycle into 16 frames by previously described methods. 
All images were corrected for radioactive decay and nor-
malized to a 3 minute acquisition period. A 3 point temporal 
and 9 point spatial smoothing program was then applied to 
all studies. Background was determined by an interpolative 
algorithm. Ejection fraction determination was performed 
by the manual assignment of regions of interest by three 
experienced observers who were blinded to the identity of 
the patient and exercise/dopamine status; results were av-
eraged. The interobserver variability for such data analysis 
has been previously demonstrated to be 1.2 ± 1.8% in our 
laboratory, again blinded, with a correlation of ejection 
fractions to contrast angiography of r = 0.95. 
Further, regional wall motion was analyzed indepen-
dently by two experienced observers. The left ventricle was 
divided into three regions, posterolateral, inferoapical and 
septal, each region being supplied predominantly by the 
circumflex, posterior descending and left anterior descend-
ing coronary arteries, respectively. Wall motion was as-
sessed subjectively during a continuous loop movie display 
and each segment was classified as hyperkinetic, normal, 
mildly hypokinetic, moderately hypokinetic or akinetic/ 
dyskinetic (scored as 0,1,2,3 and 4, respectively). Scores 
of the two observers were averaged. Thus, a patient with 
generalized hyperkinesia would have a wall motion score 
of 0 and if all three segments were moderately hypokinetic, 
the score assigned would be 9. A normal wall motion re-
sponse was defined as an improvement, that is, a decrease, 
in the score from rest to maximal stress. 
Relative end-diastolic volume changes were calculated 
by determining the percent change in end-diastolic counts 
1) from rest to maximal exercise, 2) from rest to maximal 
dopamine infusion, 3) from rest before exercise to rest be-
fore dopamine, and 4) from maximal exercise to maximal 
dopamine infusion. These analyses were performed on im-
ages corrected for radioactive decay and different periods 
for acquisition of data. 
Study protocol. This protocol was approved by the Uni-
versity of Western Ontario Standing Committee on Human 
Research. All patients were studied in the supine position 
without premedication. A modified 12 lead electrocardio-
gram was recorded each minute during exercise and do-
pamine stress. Modified leads V 4 through V 6 were moni-
tored continuously. ST segment depression was measured 
by determining the maximal degree of J-point depression in 
association with either horizontal or downs loping ST seg-
ments in any of the 12 monitored leads, at the point of 
maximal exercise stress and just before termination of the 
dopamine infusion. 
[n a preliminary group of 11 subjects, exercise stress and 
dopamine infusion were performed in random sequence, 
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with a 30 minute rest period between studies. After a 4 
minute radionuclide angiogram at rest, exercise was per-
formed to a symptom-limited maximum, starting at 200 
kg·mlmin with 200 kg'mlmin increments every 4 minutes, 
with a radionuclide angiogram acquired during the last 3 
minutes of each 4 minute stage. Blood pressure was mon-
itored by the cuff method during each exercise stage. A 
separate rest study with a 4 minute radionuclide angiogram 
was obtained before the dopamine infusion, which was then 
begun at 2.5 /Lg/kg per min, maintained for 5 minutes, with 
dosage increments of 2.5 /Lg/kg per min every 5 minutes 
to a maximum of 15 /Lg/kg per min, with radionuclide 
angiograms being obtained during the last 3 minutes of each 
5 minute stage. The infusion was terminated if significant 
angina, ischemic electrocardiographic changes or nausea 
developed. Nitroglycerin was not administered between 
studies. 
When it became apparent that heart rates-and, there-
fore, rate-pressure products-comparable with those during 
exercise were not being achieved with the dopamine infusion 
in this initial group, the protocol was modified as follows 
for the subsequent group of 41 subjects. In addition to do-
pamine, atropine (0.6 mg) was given intravenously I) just 
before drug infusion, 2) between the 5.0 and 7.5/Lg/kg per 
min infusions, and 3) between the 10.0 and 12.5 /Lg/kg per 
min infusions. This change in the protocol necessitated per-
forming the exercise study first in all subjects because the 
effects of atropine would have persisted beyond 30 minutes 
and contaminated the exercise results if the dopamine in-
fusion was performed first. No antianginal medication was 
administered after exercise stress. However, if angina de-
veloped during dopamine infusion and did not improve within 
2 minutes of discontinuation of the infusion, nitroglycerin, 
0.6 mg was administered sublingually. If there was no sig-
nificant symptomatic response to this, either 0.05 mg/kg of 
propranolol or 0.07 mg/kg of verapamil was injected intra-
venously. These latter two agents were administered in five 
patients, and produced prompt relief of anginal symptoms 
in each. 
Catecholamine assays. To determine whether, at 30 
minutes after exercise, there was persistent hypercatecho-
laminemia that would contaminate the response to dopamine 
infusion, venous blood samples were obtained from the right 
median antecubital vein in the latter group of 41 subjects 
who received atropine I) immediately before exercise, and 
2) 30 minutes after termination of exercise. Samples were 
analyzed for epinephrine and norepinephrine concentrations 
by the radioenzymatic technique. 
Statistical analysis. Results of heart rate, blood pres-
sure, rate-pressure (heart rate x systolic pressure), ejec-
tion fraction, change in ejection fraction, wall motion scores, 
end-diastolic counts and catecholamine values were ana-
lyzed by Student's t test for paired data. Sensitivities and 
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specificities were calculated and comparisons were made 
between interventions by McNemar's chi-sqaure analysis. 
Results 
Coronary anatomy. In the preliminary group of II pa-
tients, 4 had no significant coronary artery disease and 7 
had significant disease. Three had single vessel disease, one 
double, two triple and one isolated left main coronary artery 
disease. 
Among the remaining 41 subjects, there were 9 subjects 
with normal coronary arteries, 3 of whom were receiving 
a beta-adrenergic blocking agent, and 32 with coronary ar-
tery disease, 17 of whom were receiving a beta-adrenergic 
blocking agent. Ten had single, 13 double, 7 triple and 2 
left main coronary artery disease in combination with triple 
vessel disease. 
Adverse reactions or complications. No complications 
occurred as a result of either exercise or dopamine admin-
istration. Angina did not occur during either exercise or 
dopamine infusion in any of the normal subjects studied. 
In the preliminary group, all seven patients with coronary 
artery disease experienced angina during exercise, but none 
noted any chest discomfort during dopamine infusion. How-
ever, in the group that received dopamine plus atropine, 23 
patients experienced angina during exercise and of these 21 
also experienced angina during dopamine infusion. Of the 
remaining 9 patients, 1 had angina during dopamine infusion 
but not during exercise. Eight subjects did not have angina 
during either procedure, and the exercise was terminated 
because of leg fatigue. 
In the preliminary group. three of four normal subjects 
received the maximal dose of dopamine (15 /Lg/kg per min); 
the infusion in the fourth subject was tertninated at 10 /Lg/kg 
per min because of the development of nausea. Of the seven 
patients with coronary artery disease, four completed the 
infusion protocol, and the remaining three received 12.5 
/Lg/kg per min as the maximal dose because they developed 
nausea. 
In the latter group of 41 subjects. 2 of 9 normal subjects 
received the maximal dose and 6 received 12.5 /Lg/kg per 
min. One received 10 /Lg/kg per min and the infusion was 
tenninated prematurely because of mild nausea. Eleven of 
32 patients with coronary artery disease received the max-
imal infusion dose. Of the remaining 21 patients, 11 re-
ceived 12.5, 7 received 10 and 3 received 7.5 /Lg/kg per 
min. The infusion was terminated prematurely in three pa-
tients because they developed nausea and in the other pa-
tients because they developed significant ischemic chest pain. 
Other than nausea, the only side effect reported was the 
sensation of palpitations during the combined dopamine-
atropine infusion. This symptom was not reported when 
dopamine was given without atropine. 
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Table 1. Hemodynamic Data in 41 Patients 
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Normal Subjects Patients With Coronary Artery Disease 
(n = 9) (n = 32) 
Ex Oop Ex Dop 
RHR (beats/min) 74.1 ± 17.3 80.8 ± 15.7 67.4 ± 11.4 69.8 ± 9.7 
MHR (beats/min) 129.4 ± 18.5 120.9 ± 22.5 100.3 ± 20.1 107.3 ± 20.4 
RSBP (mm Hg) 144.2 ± 24.1 137.3 ± 22.3* 138.7 ± 16.3 131.3 ± 12.6§ 
MSBP (mm Hg) 202.2 ± 30.0 197.4 ± 30.1 175.7 ± 19.5 186.3 ± 22.1 t 
RDBP (mm Hg) 89.1 ± 11.0 87.3 ± 8.3 86.6 ± 8.0 84.7 ± 7.7 
MDPB (mm Hg) 102.2 ± 6.7 99.1 ± 15.9 99.6 ± 10.9 97.2 ± 12.1 
RDP (mm Hg/min x 102) 106.1 ± 26.2 110.4 ± 23.4 93.9 ± 21.7 91.7 ± 15.2 
MOP (mm Hg/min x 102) 263.4 ± 59.4 237.9 ± 55.0 183.1 ± 43.0 200.3 ± 47.2 
REF(%) 69.1 ± 5.5 70.4 ± 4.8 64.7 ± 8.4 64.0 ± 9.6 
MEF(%) 70.9 ± 5.5 74.8 ± 4.0* 61.5 ± 10.7 66.5 ± 11.8" 
AEF(%) + 1.8 ± 6.6 +4.3 ± 4.5 -3.2 ± 7.0 +2.5 ± 8.2+ 
MST (mm) 0.7 ± 0.3 0.3 ± 0.3 1.5 ± 1.4 1.2 ± 1.4 
RWMS 2.8 ± 0.5 2.8 ± 0.9 3.9 ± 1.4 3.8 ± 1.5 
MWMS 2.2 ± 1.4 1.2 ± 1.2* 4.5 ± 2.1 3.3 ± 2.8" 
Values are expressed as mean ± SO. *p < 0.05, tp < 0.02, +p < 0.005, §p < 0.001, lip < 0.0025. Oop 
= dopamine infusion; Ex = exercise; MOBP = maximal stress diastolic blood pressure; MDP = maximal 
stress rate-pressure product; MEF = maximal stress left ventricular ejection fraction; MHR = maximal stress 
heart rate; MSBP = maximal stress systolic blood pressure; MST-ST segment depression at maximal stress; 
MWMS = maximal stress wall motion score; RDBP = diastolic blood pressure at rest; RDP = rest rate-
pressure product; REF = left ventricular ejection fraction at rest; RHR = heart rate at rest; RSBP = systolic 
blood pressure at rest; RWMS = wall motion score at rest; AEF = change in left ventricular ejection fraction 
from rest to maximal stress. 
Heart rate, blood pressure and rate-pressure product 
(Table 1). In the preliminary group of 11 subjects who did 
not receive atropine, the maximal heart rate during dopa-
mine infusion was significantly less than that during exer-
cise, 88.0 ± 35.8 versus 129.3 ± 30.0 beats/min (p < 
0.05) in normal subjects and 87.6 ± 22.6 versus 118.9 ± 
21.1 beats/min (p < 0.05) in patients with coronary artery 
disease. As a result, comparable differences were also ob-
served in rate-pressure product, 155.0 ± 52.5 versus 213.3 
± 51.4 mm Hg/min x 102 (p < 0.02) in normal subjects 
and 161.0 ± 48.6 versus 126 ± 45.6 mm Hg/min x 102 
(p < 0.(03) in patients with coronary artery disease. Not 
unexpectedly, a 6.3% absolute increase in ejection fraction 
was observed with dopamine infusion, whereas a 3.3% de-
crease was produced by exercise stress. 
As dopamine alone clearly was not capable of achieving 
a sufficiently high rate-pressure product for induction of 
ischemia, presentation of results subsequently is limited to 
the group of 41 subjects who received both atropine and 
dopamine. In the 9 normal subjects, maximal stress heart 
rates were statistically similar, 120.9 ± 22.5 with dopamine 
versus 129.4 ± 18.5 beats/min with exercise. Systolic blood 
pressure at rest was slightly lower before dopamine infusion, 
137.3 ± 22.3 versus 144.2 ± 24.1 mm Hg (p < 0.05), 
whereas heart rate and diastolic blood pressure at rest and 
maximal stress systolic and diastolic blood pressures were 
similar. As would be expected, both rest and maximal rate-
pressure products were similar between procedures. 
In the 32 patients with coronary artery disease, rest and 
maximal stress heart rates were similar. Systolic blood pres-
sure at rest was slightly lower before dopamine infusion, 
131.3 ± 12.6 versus 138.7 ± 16.3 mm Hg (p < 0.001), 
whereas diastolic blood pressures at rest were similar. Max-
imal stress systolic blood pressure was higher with dopamine 
and maximal stress diastolic blood pressures were similar. 
Rate-pressure products at rest were similar, whereas the 
maximal stress rate-pressure product was significantly higher 
with dopamine, 200.3 ± 47.2 versus 183.1 ± 43.0 mm 
Hg/min x 102 (p < 0.05). 
ST segment changes. In the nine normal subjects, there 
was no significant difference in mean ST segment depres-
sion. Four had 1.0 mm or greater ST segment depression 
with exercise versus two with dopamine. In the 32 patients 
with coronary artery disease, there was again no significant 
difference in ST segment depression, 1.5 ± 1.4 mm with 
exercise versus 1.2 ± 1.4 mm with dopamine, with 18 
having 1 mm or greater ST segment depression with exercise 
and 17 with dopamine. 
End-diastolic count changes. In normal subjects, the 
changes in end-diastolic counts, which reflect but are not 
necessarily equivalent to changes in volume, were: 1) rest 
to maximal exercise, an increase of 15.8 ± 14.8% (p < 
0.05); 2) rest to maximal dopamine, a decrease of 2.0 ± 
18.0% (p = NS); rest before exercise to rest before do-
pamine, a decrease of 10.2 ± 11.8% (p < 0.05); and 
maximal exercise to maximal dopamine, a decrease of 23.0 
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Table 2. Group and Individual Left Ventricular Function Assessment in 41 Patients 
Case 
I 
2 
3 
4 
5 
6 
7 
8 
9 
Mean 
± SD 
p value 
Beta-adrenergic 
Blocking 
Agent 
No 
No 
Yes 
No 
No 
Yes 
No 
No 
Yes 
Ejection Fraction (%) 
R-E R-D Ex Dop 
76 
66 
62 
62 
72 
68 
67 
72 
77 
73 
66 
69 
66 
69 
74 
72 
65 
80 
69.1 70.4 
± 5.5 ± 4.8 
NS 
A. Normal Subjects (n = 9) 
73 
65 
68 
70 
72 
78 
74 
61 
77 
77 
69 
77 
77 
78 
71 
76 
69 
79 
70.9 74.8 
± 5.5 ± 4.0 
< 0.05 
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Wall Motion Score 
R-E R-D Ex Dop 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
2.5 
3.0 
1.5 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.5 
0.5 
2.8 2.8 
± 0.5 ± 0.9 
NS 
1.5 
2.0 
4.0 
1.0 
2.0 
3.5 
2.0 
4.5 
1.5 
1.5 
0.5 
0.0 
0.0 
0.0 
3.0 
2.5 
2.5 
0.5 
2.3 1.2 
± 1.4 ± 1.2 
< 0.05 
B. Subjects With Coronary Artery Disease (n = 32) 
I 
2 
3 
4 
5 
6 
7 
8 
9 
65 
57 
70 
65 
79 
49 
65 
59 
45 
60 
71 
66 
67 
77 
56 
65 
63 
58 
67 
57 
77 
56 
73 
65 
71 
67 
76 
67 
71 
75 
68 
55 
65 
57 
77 
49 
55 
57 
49 
71 
73 
59 
68 
77 
53 
69 
58 
57 
59 
63 
81 
55 
74 
63 
69 
64 
74 
66 
74 
82 
63 
51 
50 
40 
74 
42 
53 
69 
50 
69 
72 
63 
63 
81 
52 
64 
59 
61 
58 
49 
72 
50 
74 
63 
68 
66 
74 
68 
72 
76 
74 
52 
67 
47 
68 
36 
59 
69 
51 
59 
62 
62 
71 
80 
68 
79 
59 
58 
64 
70 
66 
59 
84 
73 
76 
61 
83 
81 
79 
91 
3.0 
7.0 
3.5 
4.0 
3.0 
8.0 
3.5 
4.5 
7.0 
3.5 
2.5 
3.5 
3.0 
3.0 
3.0 
3.0 
5.0 
3.5 
3.0 
5.0 
1.5 
5.5 
3.5 
4.0 
2.5 
3.0 
3.0 
4.5 
3.0 
3.0 
3.0 
7.5 
3.5 
5.0 
3.0 
6.0 
3.5 
3.0 
8.5 
1.5 
3.5 
3.5 
3.5 
3.0 
3.5 
3.0 
3.5 
5.5 
3.5 
4.0 
3.0 
6.5 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
2.0 
3.0 
5.0 
7.5 
7.5 
8.0 
3.0 
9.0 
5.5 
3.0 
9.0 
3.0 
2.5 
3.0 
3.0 
J.5 
3.5 
3.0 
6.0 
4.0 
4.5 
6.5 
1.5 
6.5 
2.5 
5.0 
3.0 
3.5 
3.5 
3.5 
3.0 
4.0 
1.5 
9.0 
3.5 
8.0 
2.5 
8.5 
2.0 
0.5 
8.5 
4.5 
3.0 
3.0 
3.0 
0.0 
2.0 
0.0 
2.5 
8.5 
4.0 
3.5 
3.0 
6.0 
0.5 
1.5 
0.0 
4.5 
J.5 
1.0 
0.0 
0.5 
10 
II 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
31 
32 
No 
No 
No 
Yes 
Yes 
Yes 
No 
Yes 
No 
No 
Yes 
Yes 
Yes 
No 
Yes 
No 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
Yes 
No 
Yes 
Yes 
Yes 
No 
Yes 
Yes 51 47 48 59 5.5 4.5 7.0 5.0 
Mean 
± SD 
P value 
64.7 64.0 61.5 66.5 3.9 3.8 4.5 3.3 
± 8.4 ± 9.6 ± 10.7 ± 11.8 ± 1.4 ± 1.5 ± 2.1 ± 2.8 
NS P < 0.0025 NS < 0.0025 
Dop = dopamine; Ex = exercise; R-D = rest before dopamine; R-E = rest before exercise. 
± 14.4% (p < 0.01). In patients with coronary artery dis-
ease, the changes in end-diastolic counts were: rest to max-
imal exercise, an increase of 14.3 ± 10.0% (p < 0.05); 
rest to maximal dopamine, an increase of 7.2 ± 16.8 % (p 
= NS); rest before exercise to rest before dopamine, a 
decrease of 12.7 ± 14.1 % (p < 0.05) and maximal exercise 
to maximal dopamine, a decrease of 16.3 ± 16.6% (p < 
0.05). 
Eight of nine normal subjects had a decrease of end-
diastolic counts from rest before exercise to rest before 
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dopamine and nine at maximal stress. Of the 32 patients 
with coronary artery disease, 27 had a decrease at rest and 
26 at maximal stress. 
To evaluate whether this decrease in countsfrom exercise 
to dopamine studies was due to leg positioning, a separate 
group of 15 patients with documented coronary artery dis-
ease without valvular disease, undergoing clinical radio-
nuclide angiography, had an initial study performed with 
the legs flat and a second study with the legs elevated. The 
results in this group demonstrated a difference in end-dia-
stolic counts of 4.7 ± 10.1 % (p = NS) from the legs 
elevated position (as was the case with exercise) versus legs 
flat (as for dopamine infusion). 
Ejection fraction (Table 2). In the nine normal sub-
jects. the ejection fractions at rest for the exercise and do-
pamine studies were similar, as were the stress ejection 
fraction changes. During exercise, ejection fraction in-
creased from 69.1 ± 5.5 to 70.9 ± 5.5% and with the 
dopamine infusion from 70.4 ± 4.8 to 74.8 ± 4.0. Only 
four subjects had an increase in ejection fraction with ex-
ercise (range 6 to 10%), with the remaining five manifesting 
either no increase (two subjects) or a decrease of 1 to 11 % . 
The subject with the 11 % decrease had a marked hyperten-
sive response to exercise. With dopamine, seven subjects 
had an increase in ejection fraction of 3 to 12%, with a 
decrease in the remaining two subjects of 1 and 3%, re-
spectively. In five subjects the maximal ejection fraction 
was observed during one of the intermediate stages, with a 
decrease from this peak value at the maximal dopamine 
infusion rate for that subject. This phenomenon was not 
observed during exercise. 
In the patients with coronary artery disease. the ejection 
fractions at rest for the exercise and dopamine studies were 
statistically similar. However, the response to stress differed 
between exercise with a 3.2 ± 7.0% decrease from 64.7 
± 8.4 to 61.5 ± 10.7% versus dopamine with a 2.5 ± 
8.12% increase from 64.0 ± 9.6 to 66.5 ± 11.8% (p < 
0.005). Twenty-one of the 32 patients had a decrease in 
ejection fraction with exercise, as compared with 8 with 
dopamine. To compare the sensitivity and specificity of the 
dopamine infusion technique with exercise in the detection 
of coronary artery disease, some of the criteria used by 
various institutions for an abnormal response were applied 
to the present results. However, it must be understood that 
the "normal" response to atropine and dopamine has not 
been established in the present study, which was limited to 
nine subjects without coronary artery disease. 
If the criterion for an abnormal response was defined as 
afailure of the ejection fraction to increase by 5% or more. 
the sensitivity was 91 % for exercise and 56% for dopamine 
(p < 0.005). If the criterion was 7%, the respective values 
were 94 and 66% (p < 0.01) and with a criterion of 10%, 
the respective values were 97 and 78% (p < 0.025). The 
corresponding specificity for the 5% criterion was 44% for 
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exercise and 33% for dopamine (p = NS); for the 7% 
criterion, 33% for exercise and 33% for dopamine (p = 
NS); and for the 10% criterion, 11 % for exercise and 11 % 
for dopamine (p = NS). 
The differences in ejection fraction response between 
exercise and dopamine in patients with coronary disease 
occurred despite comparable rate-pressure products being 
achieved during the two procedures (Fig. 1). These results 
were obtained from 22 patients who could exercise at least 
two stages. Other than at rest, at all values of rate-pressure 
product, the ejection fraction during dopamine infusion was 
higher than that observed during exercise. The highest ejec-
tion fraction occurred during an intermediate stage, but it 
decreased at maximal infusion rates, although not to the 
level observed during exercise. 
Wall motion analysis (Table 2). In the nine normal sub-
jects, the wall motion scores at rest before exercise and 
before dopamine were similar. However, the maximal stress 
wall motion scores were dissimilar at 2.2 ± 1.4 with ex-
ercise versus 1.2 ± 1.2 with dopamine (p < 0.05). Five 
subjects had a normal wall motion response to exercise 
(specificity 56%) versus seven of nine to dopamine (spec-
ificity 78%). 
In the coronary artery disease group, the wall motion 
scores at rest were again similar. However, the stress wall 
motion scores were significantly different, with a value of 
4.5 ± 2.1 with exercise versus 3.3 ± 2.8 with dopamine 
(p < 0.0025). Twenty-five of the 32 patients had an ab-
Figure 1. Relation between ejection fraction (EF) and double 
(rate-pressure) product during exercise (Ex) and dopamine (Oop) 
infusion in those patients with coronary artery disease who were 
able to exercise at least two stages and who received atropine 
during the drug infusion. 01 = first dopamine infusion rate; 
02 = second dopamine infusion rate; 03 = third dopamine in-
fusion rate; O-Max = maximal dopamine infusion rate; EI = 
first exercise stage; E-Max = maximal exercise stage; R-O = rest 
before dopamine; R-E = rest before exercise. 
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nonnal wall motion response with exercise (sensitivity 78%) 
versus 11 with dopamine (sensitivity 34%). 
Serum catecholamines. There was no significant dif-
ferences between norepinephrine levels at rest (1,070 ± 
240 pmoVliter before exercise versus 1, 131 ± 263 pmoVliter 
before dopamine) and none between epinephrine levels 
(255 ± 31 pmol/liter before exercise versus 271 ± 29 
pmol/liter before dopamine). 
Discussion 
Exercise physiology. Exercise stress testing produces a 
decrease in parasympathetic activity while sympathetic ac-
tivity concurrently increases (10), producing increases in 
heart rate and stimulus to myocardial contractility. In ad-
dition, vasodilation occurs in exercising vascular beds and 
vasoconstriction elsewhere, with a net decrease in systemic 
vascular resistance. Autoregulation, in the absence of coro-
nary artery stenosis, produces an increase in coronary flow 
and a decrease in coronary vascular resistance. However, 
in the presence of a fixed coronary artery stenosis, auto-
regulation fails to produce appropriate increases in blood 
flow to meet metabolic requirements. Thus, ventricular con-
tractility progressively decreases. 
RadionucIide angiography. Using supine exercise, Borer 
et al. (11) originally reported a sensitivity of 90% and spec-
ificity of 100% for the detection of coronary artery disease 
using ejection fraction response and wall motion analysis. 
However, subsequent reports (12-17) have varied, with lower 
values occasionally demonstrated for both sensitivity (range 
53 to 98%) and specificity (range 58 to 100%). The lower 
sensitivities may be due in part to methods of data analysis, 
use of beta-adrenergic blocking agents and failure of patients 
to achieve cardiac-limited end points. The variation in spec-
ificity, even excluding patients with valvular disease and 
cardiomyopathy, is probably influenced by small vessel 
coronary disease, age, high baseline contractile state of 
myocardium, abnonnal responsiveness of the peripheral 
vascular or autonomic nervous system, or both, altered ven-
tricular loading conditions and antianginal agents (18-21). 
To improve the sensitivity for the detection of disease in 
patients with physical disabilities, alternative fonns of stress 
testing in conjunction with radionuclide angiography have 
been proposed. With the cold pressor test, sensitivity has 
varied from 70 to 80% and specificity from 0 to 95% (1-3). 
Because the test produces marked increases in blood pres-
sure without concurrent parasympathetic deactivation, it is 
likely that what is observed is a nonspecific response of left 
ventricular function to increased afterload. 
Pharmacologic stress. Both isoproterenol and norepi-
nephrine have been shown to induce ischemic dysfunction 
in isolated heart preparations and in conscious dogs (22-27). 
Furthermore, Elliott (6) and Heiman and coworkers (28) 
reported several patients with documented coronary artery 
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disease who developed symptoms of angina and glycolytic 
metabolism during isoproterenol infusion. However, be-
cause of the risk of induction of serious ventricular arrhyth-
mias, the use of isoproterenol was not considered to be 
appropriate for our study. In a comparative study by Vatner 
et al. (29) of isoproterenol, norepinephrine, epinephrine, 
dobutamine and dopamine in conscious dogs, with the ex-
ception of isoproterenol, dopamine produced the greatest 
increase in heart rate (126 versus 50 beats/min) and, for this 
study, was thought to be the most suitable agent for inducing 
ischemic left ventricular dysfunction in the setting of coro-
nary artery disease. This agent, however, produces an in-
crease in systemic vascular resistance at doses greater than 
7.5 j.Lg/kg per min, which differs from the decrease in vas-
cular resistance seen during exercise. This property was 
believed to enhance the chances for the development of 
ischemic dysfunction at higher dopamine doses. The de-
crease in ejection fraction after the initial increase observed 
at lower doses in the present study may be due to this 
phenomenon. 
Responses to dopamine versus exercise. Despite the 
findings of Vatner et al. (29), without atropine, dopamine 
\ did not produce any significant increase in heart rate from 
baseline values, presumably because of a vagally mediated 
reflex in response to elevation in systolic blood pressure 
(30). As a result of the rate-pressure product with dopamine 
failing to increase to match that observed with exercise, 
ejection fraction increased with dopamine while decreasing 
with exercise from 60.9 to 57.6% in patients with coronary 
artery disease. 
With atropine added to the protocol, comparable maximal 
heart rates and rate-pressure products were achieved. Never-
theless, despite a similar improvement in ejection fraction 
occurring in normal subjects with both procedures, in pa-
tients with coronary artery disease dopamine produced an 
increase in ejection fraction of 2.5% versus a decrease of 
3.2% with exercise. In addition, only 11 of 32 patients had 
an abnormal wall motion response with dopamine versus 
25 of 32 with exercise, despite similar electrocardiographic 
manifestations of ischemia. For all criteria for abnormality, 
the ejection fraction response with dopamine was signifi-
cantly less sensitive for coronary artery disease with do-
pamine than with exercise. Specificity was similarly low for 
both procedures, presumably for the reasons previously cited 
(18-21). 
There are a few possible explanations for the differences 
observed between ejection fraction response with dopamine 
and exercise in patients with coronary artery disease. Base-
line hemodynamic status, which may affect the response to 
stress, may not have been comparable. Despite statistically 
similar catecholamine levels, mean heart rates and diastolic 
blood pressures at rest, the mean systolic blood pressure 
was statistically lower before dopamine infusion in both 
normal subjects and patients with coronary artery disease. 
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Further, despite similar mean ejection fractions at rest, 4 of 
9 normal subjects and 9 of 32 patients with coronary artery 
disease had differences of 5% or greater, in baseline ejection 
fractions. In addition, left ventricular volumes were prob-
ably smaller because there were 12.7% fewer end-diastolic 
counts (corrected for decay and acquisition time) before 
dopamine infusion. This difference cannot be accounted for 
solely on the basis of leg positioning because only a 4.7% 
statistically insignificant difference was seen in an indepen-
dent study of 15 subjects. These smaller volumes were also 
seen at the maximal dopamine infusion rate. Thus, myo-
cardial tension and oxygen requirements may have been less 
in comparison with the exercise procedure both before and 
during the dopamine infusion. 
Another possibility is that the positive inotropic stimu-
lation from norepinephrine and epinephrine released during 
exercise may have been greater than that produced by do-
pamine, despite similar rate-pressure products. A third pos-
sibility may be differences in myocardial metabolic stimulus 
between dopamine and exercise, with a more efficient path-
way associated with lower oxygen requirements in response 
to the former. These latter hypotheses require further 
investigation. 
Conclusion. Dopamine, without atropine, fails as an agent 
capable of reliably producing manifestations of ischemia. 
In the absence of significant increases in heart rate and rate-
pressure product, myocardial oxygen demands are not in-
creased greatly, and comparable positive inotropic effects 
are observed between normal subjects and patients with 
coronary artery disease. When atropine is combined with 
dopamine, with similar heart rates and rate-pressure prod-
ucts, ischemic manifestations are observed in patients with 
coronary artery disease, but neither with the frequency nor 
to the degree observed with exercise. In this study, the 
differences may have been due to dissimilar baseline hemo-
dynamic status and inotropic or metabolic effects of do-
pamine, or both, in comparison with exercise. 
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